INTRODUCTION
============

Periodontitis is a multifactorial disease with microbial dental plaque as the initiator of periodontal disease.[@b1-0020102] However, the manifestation and progression of periodontitis is influenced by a wide variety of determinants and factors including subject characteristics, social and behavioral factors, systemic factors, genetic factors, tooth-level factors, microbial composition of dental plaque and other emerging factors.[@b2-0020102]

Smoking is one of the major environmental risk factors for periodontal diseases.[@b3-0020102]--[@b11-0020102] In studies where plaque accumulation was similar in smokers and non-smokers or was adjusted, current smokers had deeper probing depths,[@b5-0020102],[@b6-0020102],[@b12-0020102]--[@b14-0020102] greater attachment loss,[@b10-0020102],[@b12-0020102],[@b13-0020102],[@b15-0020102] more bone loss,[@b4-0020102],[@b11-0020102],[@b16-0020102] and fewer teeth.[@b13-0020102],[@b15-0020102] Smokers also exhibit more supragingival calculus deposits.[@b17-0020102]

It is widely accepted that smoking impairs various aspects of innate and immune host responses.[@b18-0020102],[@b19-0020102] Numerous functions of oral or peripheral neutrophil are negatively affected by smoking or nicotine exposure, including phagocytosis,[@b20-0020102] superoxide and hydrogen peroxide generation,[@b21-0020102],[@b22-0020102] integrin expression,[@b23-0020102] and protease inhibitor production.[@b24-0020102] Alterations in gingival crevicular fluid[@b25-0020102]--[@b27-0020102] and peripheral blood mononuclear cell[@b28-0020102] levels of various cytokines in smokers, tipping the balance in favor of tissue breakdown, have been noted.

Until relatively recently, less attention has been devoted to exploring the role that chronic oral diseases may have on systemic health. The hypothesis that oral conditions, such as periodontal infections, may be risk factors or indicators for important medical outcomes represents a paradigm shift in thinking about causality and the directionality of oral and systemic associations. The subgingival microbiota in patients with periodontitis provides a significant and persistent gram-negative bacterial challenge to the host. These organisms and their products, such as lipopolysaccharide (LPS), have ready access to the periodontal tissues and to the circulation via the sulcular epithelium, which is frequently ulcerated and discontinuous.[@b29-0020102] It has therefore been speculated that periodontitis results in a low grade systemic inflammation.

Anemia of chronic disease (ACD) is a cytokine-mediated anemia commonly encountered in clinical practice and characterized by hypoferramia with adequate reticuloendotelial iron stores, normal to elevated ferritin concentrations and it is a frequent complication of chronic inflammatory conditions.[@b30-0020102],[@b31-0020102] Hutter et al[@b32-0020102] suggested that periodontitis has chronic and systemic effects and that periodontitis may tend towards anemia.

The aim of present study was to evaluate the influence of cigarette smoking on clinical parameters and the signs of ACD in patients with chronic periodontitis.

MATERIALS AND METHODS
=====================

Selection of Patients
---------------------

The study population included 88 patients, 45 smokers and 43 non-smokers in the age range of 30--69 (45.5±8.5) and 32--61 years (45.8±7.9), respectively. The patients had chronic periodontitis as evidenced a probing depth of 6 mm or more at 80% of the proximal sites and bone loss \>50% by radiographs.[@b33-0020102] All participants were in principal periodontally untreated and had not previously received surgical therapy and were drawn from the patients with chronic periodontitis at the Department of Periodontology. All subjects were systemically healthy, with no medical condition that would effect their participation in the study. An extensive medical history was taken both by a written questionnaire and by interview. Exclusion criteria applied were a course of anti-inflammatory or antimicrobial therapy within the previous 3 months, a history of use of vitamin or iron supplementation within the previous 3 months, and any special dietary requirements (e.g. Coeliac disease). Pregnant women and individuals who suffered, apart from periodontitis, from any given acute or chronic medical condition, including diabetes, viral, fungal or bacterial infections, or had recent trauma or tooth extractions were also excluded. None of them were alcohol consumers. The purpose and nature of the study, including the types of clinical measurements and sample collection, were explained to all potential subjects. After reading and signing the consent form, the subjects were enrolled into the study. The study was approved by the Medical Ethical Committee of our institution.

For all participants smoking habits were recorded and patients were classified as either current smokers \[S (+)\], i.e., regular daily smoke 20 cigarettes (45 patients), or non-smokers \[S (−)\], i.e., who had never smoked tobacco (43 patients). All smokers were cigarette smokers. Smoking condition of the patients was calculated as: Number of cigarette per day/number of years smoked. Patients who have been smoking between 15--20 years were included in the study. The mean age of current smokers and non-smokers was 45.5±8.5 and 45.8±7.9, respectively. The age differences between groups were not statistically significant (P\>.05). Body mass index (BMI) measures of the patients were also recorded and there was not statistically significant difference between groups (P\>.05).

Clinical recordings
-------------------

Supragingival plaque was scored using Plaque index (PI)[@b34-0020102] Gingival inflammation was scored using Gingival index (GI)[@b35-0020102] Bleeding on probing (BOP) was measured dichotomously.[@b36-0020102] Probing depth (PD) and clinical attachment level (CAL) measures were obtained from the six points of the teeth using a conventional periodontal probe (Hu-Friedy, Chicago, IL, USA). The probe was directed parallel to the long axis of the tooth. CAL measurements were made from the cemento-enamel junction to the bottom of the sulcus. All clinical data were recorded by one examiner (EOE).

Red blood cell analyses
-----------------------

Venous blood samples were obtained between 8.30 and 11.00 AM by venepuncture in the antecubital fossa without excessive venous stasis. The blood was taken into EDTA containing vacuum tubes (HEMA, Germany) in the Faculty of Medicine, Department of Biochemistry. The laboratory analysis of differential blood count was performed immediately with the Sysmex XT 2000i (Roche, Switzerland).

In standardized and automated procedures, numbers of erythrocytes, hemoglobin, hematocrit, iron, ferritin levels, mean corpuscular volume of erythrocytes (MCV), mean corpuscular hemoglobin (MCH) and the mean corpuscular hemoglobin concentration (MCHC) were calculated.

Statistical analysis
--------------------

Data were expressed as means and standard deviations. The statistical significance of differences between groups was tested with Mann Whitney U Test. Simple pair wise correlations were calculated according to the rank correlation of Pearson. The null-hypothesis was rejected at P\<.05.

RESULTS
=======

Clinical characteristics
------------------------

The clinical characteristics of this study are shown in [Table 1](#t1-0020102){ref-type="table"}. When the clinical parameters were compared between groups, in S (+) group, PI, PD and CAL were significantly higher compared to S (−) (P\<.05). There were not any differences between smokers and non-smokers in the mean values of GI and BOP (P\>.05). Both study groups had a comparable number of teeth present (mean 24.6 smokers and 24.5 for non-smokers). There were no differences between groups with respect to gender.

Serum sample levels of red blood cells
--------------------------------------

The mean values of serum parameters are shown in [Table 2](#t2-0020102){ref-type="table"}. The number of erythrocytes and the levels of hemoglobin, hematocrit and iron were lower in smokers compared to non-smokers (P\<.05). The MCV, MCH, MCHC and ferritin levels were not different between groups.

Correlations
------------

Correlations between mean levels of serum and clinical parameters are shown in [Tables 3](#t3-0020102){ref-type="table"} and [4](#t4-0020102){ref-type="table"} for S (+) and S (−), respectively. There were no significant correlations between the mean levels of serum parameters and clinical parameters in S (−) group (P\>.05). In S (+) group, there were negative correlation between CAL and the level of RBC in serum values (P\<.05), and positive correlations with Fe, MCH and MCHC (P\<.01). In this study group, there were also positive correlations between mean PD values and the levels of MCV (P\<.05), MCH and MCHC in serum (P\<.01).

DISCUSSION
==========

It is now well established from a large body of epidemiologic evidence that cigarette smoking is the major preventable risk factor in the incidence progression of periodontal disease.[@b9-0020102],[@b10-0020102] It is suggested that periodontitis is associated with an increased risk for systemic diseases like cardiovascular diseases, cerebrovascular ischemia and atherosclerosis.[@b37-0020102] It has been also shown that periodontitis patients have elevated levels of white blood cells, and elevated plasma levels of C-reactive protein.[@b38-0020102]--[@b42-0020102] Substantial scientific data indicate that the localized infections characteristic of periodontitis can have a significant effect on the systemic health of both humans and animals.[@b43-0020102] Just as the periodontal tissues mount an immunoinflammatory response to bacteria and their products, systemic challenge with these agents also induces a major vascular response. This host response may offer explanatory mechanisms for the interactions between periodontal infection and a variety of systemic disorders.[@b44-0020102]

In the present study, smokers with chronic periodontitis have lower levels of hemoglobin, hematocrit, iron and number of erythrocytes than non-smokers. Ferritin levels were not different between groups. These findings were in parallel direction of the symptoms of ACD. MCV levels are the main determinants of the some kinds of anemia. A depressed level of MCV (microcytosis) relates anemia to iron deficiency and elevated level of MCV (macrocytosis) relates anemia to vitamin deficiency.[@b45-0020102],[@b46-0020102] In our study, MCV levels were between the reference values, as mostly seen in ACD and called as normocytosis.

It has been proposed that hepcidin is a primary factor in the pathogenesis of the ACD, a cytokine-mediated anemia commonly encountered in clinical practice and characterized by hypoferraemia with adequate reticuloendothelial iron stores.[@b31-0020102] Previous studies indicated that IL-6 mediates hepcidin increase and consequent hypoferremia during inflammation.[@b47-0020102] It was found that hepcidin mRNA was increased in the livers of lipopolysaccharide (LPS)-treated mice and LPS-treated hepatocytes.[@b48-0020102] This also suggested that hepcidin could be the pathogenic mediator of ACD. Kemna et al[@b49-0020102] showed the importance of IL-6-hepcidin axis in development of hypoferremia in inflammation and highlight the rapid responsiveness of this iron regulatory system. Nemeth et al[@b50-0020102] found that patients with ACD due to inflammatory disorders or infections had markedly increased excretion of urinary hepcidin. In vitro stimulation of fresh human hepatocytes with a panel of cytokines showed strong induction of hepcidin mRNA by IL-6, but not IL-α or TNF-α, indicating that IL-6 may be the mediator of hepcidin induction by inflammation. Although there aren't any studies about the relationship between hepcidin and periodontal diseases or the effect of smoking on hepcidin, it is well known that pro-inflammatory cytokines and mediators are significantly elevated, with gingival inflammation during the destructive phase of periodontitis.[@b51-0020102]--[@b56-0020102] There is also strong evidence for cytokines eliciting the systemic acute-phase response in various chronic inflammatory diseases.[@b57-0020102],[@b58-0020102] Hutter et al[@b32-0020102] suggested that periodontitis also needs to be considered as a chronic disease which may cause lower numbers of erythrocytes and consequently lower hemoglobin levels. They mentioned that the pathogenesis for their findings is similar as reported for rheumatoid arthritis, i.e. depressed erythropoiesis by systemically circulating pro-inflammatory cytokines resulting from a local chronic inflammatory process.

Tobacco components may also modify the production of cytokines or inflammatory mediators. In smokers an imbalance in cytokine production seems to occur. Elevated concentrations of IL-6 were observed in the plasma of smokers,[@b59-0020102] as well as in the alveolar cells of healthy donors stimulated by tobacco glycoprotein.[@b60-0020102] Nicotine, one of the most deleterious products of cigarette, has been shown to increase release of IL-6 by cultured murine osteoblasts.[@b61-0020102] Giannopoulou et al[@b26-0020102] indicated that smoking interferes with cytokine production. It has also been reported that release of cytokines from peripheral neutrophils and various parameters of inflammation in plasma seem to be affected more by cigarette smoking than periodontal disease.[@b62-0020102] Such alterations in host response may affect the reparative and regenerative potential of the periodontium in tobacco smokers. In the literature it has been identified that smoking is an important factor to affect erythrocytes and related parameters.[@b63-0020102],[@b64-0020102] In the present study, our first aim was to detect the effect of smoking on ACD in the existence of chronic periodontitis. Therefore, we did not analyze the inflammatory mediators. But further studies are needed that support the findings of our study with these measurements. The current study indicates periodontitis also needs to be considered as a chronic disease and together with the effect of cigarette smoking it may cause lower numbers of erythrocytes and the levels of hemoglobin, hematocrit and iron.

The BMI measures were also collected due to well recognized effect of adiposity on systemic host response.[@b65-0020102],[@b66-0020102] Nishida et al[@b67-0020102] suggested that the immunological disorders or inflammation might be the reason that obese smokers tend to exhibit escalating poor periodontal status relative to non-obese and non-smoking individuals. Because of that obese patients were excluded from the study and also the difference between the groups was not significant.

Some of the studies interpreted the effect of cigarette smoking on the periodontium to be indirect and due to inadequate levels of oral hygiene and increased plaque accumulation among smokers relative to non-smokers.[@b12-0020102],[@b68-0020102],[@b69-0020102] In this study, PI levels of S (+) were higher than S (−).

The studies searching the effect of smoking on clinical parameters suggest that non-smokers have higher GI and BOP values than smokers.[@b3-0020102],[@b6-0020102],[@b15-0020102] But, there are conflicting results those show no significant difference between smokers and non-smokers[@b70-0020102] and smokers have higher values than non-smokers.[@b71-0020102] Pucher et al[@b72-0020102] reported that GI and BOP values were similar in smokers and non-smokers 9 months after periodontal therapy. In this study, GI and BOP values were found similar in smokers and non-smokers. However, the effects of nicotine has been disputed, some claim that the blood flow is reduced[@b73-0020102] and others claim it is significantly increased[@b74-0020102] or unchanged.[@b75-0020102]

The studies which show that PD values were higher in smokers than non-smokers are also present in literature.[@b3-0020102],[@b5-0020102],[@b12-0020102],[@b16-0020102],[@b69-0020102],[@b70-0020102],[@b76-0020102],[@b77-0020102] A significant positive correlation has been shown between smoking and CAL.[@b11-0020102],[@b15-0020102],[@b69-0020102],[@b70-0020102],[@b77-0020102],[@b78-0020102] In the present study, PD and CAL values were also higher in S (+) than S (−). The reason of increased PD and CAL levels in smokers may be depend on accumulation of dental plaque and poor oral hygiene.[@b68-0020102],[@b69-0020102],[@b79-0020102] In S (+) group, it was found negative correlation between CAL and the level of RBC in serum values and positive correlations with MCH and MCHC. In this study group, it was found positive correlations between mean PD values and the levels of MCV, MCH and MCHC in serum. According to the results of this study, it seems that smoking is an important factor to affect erythrocytes and related parameters.

CONCLUSIONS
===========

From the results of the present study, it can be stated that cigarette smoking could have an effect on the numbers of erythrocytes and the levels of hemoglobin hematocrit and iron in serum. Additionally, although cigarette smoking does not affect the degree of gingival inflammation, the amount of dental plaque, probing depth and clinical attachment loss were higher in smokers.

###### 

The mean values of clinical parameters (mean ± SD).

  Parameters   S (+) (n=45)                                        S (−) (n=43)
  ------------ --------------------------------------------------- --------------
  PI           2.06±0.33[\*](#tfn2-0020102){ref-type="table-fn"}   1.79±0.27
  GI           1.82±0.31                                           1.92±0.16
  BOP          0.56±0.40                                           0.59±0.34
  PD           5.04±0.61[\*](#tfn2-0020102){ref-type="table-fn"}   4.75±0.56
  CAL          4.84±0.51[\*](#tfn2-0020102){ref-type="table-fn"}   4.41±0.54

PI: Plaque index, GI: Gingival index, BOP: Bleeding on probing, PD: Pocket depth, CAL: Clinical attachment loss

:P\<.05 according to Mann Whitney U Test

###### 

The mean values of serum parameters in S (+) and S (−) (mean ± SD).

  Parameters     S (+) (n=45)                                          S (−) (n=43)
  -------------- ----------------------------------------------------- --------------
  RBC (106/μl)   4.88±0.48[\*](#tfn4-0020102){ref-type="table-fn"}     5.17±0.47
  HGB (g/dl)     13.48±2.19[\*](#tfn4-0020102){ref-type="table-fn"}    14.98±1.58
  HCT (%)        41.39±5.47[\*](#tfn4-0020102){ref-type="table-fn"}    45.17±3.84
  FE (μg/dl)     78.37±38.62[\*](#tfn4-0020102){ref-type="table-fn"}   97.76±39.38
  FER (ng/dl)    82.16±49.43                                           81.39±86.47
  MCV (fl)       87.32±3.83                                            84.67±7.38
  MCH (pg)       28.97±2.64                                            27.55±3.58
  MCHC (g/dl)    33.18±2.08                                            32.48±2.44

RBC: Red blood cell, HGB: Hemoglobin, HCT: Hematocrit, FE: Iron, FER: Ferritin MCV: Mean corpuscular volume of erythrocytes, MCH: Mean corpuscular hemoglobin, MCHC: Mean corpuscular hemoglobin concentration

:P\<.05 according to Mann Whitney U Test

###### 

Correlations between serum and clinical parameters in S (+) (n=45).

  Parameters     PI       GI       BOP      PD                                                CAL
  -------------- -------- -------- -------- ------------------------------------------------- -------------------------------------------------
  RBC (106/μl)   0.045    −0.125   −0.217   −0.188                                            −0.320[\*](#tfn5-0020102){ref-type="table-fn"}
  HGB (g/dl)     0.053    −0.005   0.071    −0.099                                            0.134
  HCT (%)        0.036    −0.175   −0.132   −0.062                                            −0.215
  FE (μg/dl)     −0.083   0.069    0.243    0.186                                             0.331
  FER (ng/dl)    −0.060   0.026    0.031    0.192                                             0.147
  MCV (fL)       0.040    −0.045   0.253    0.302[\*](#tfn5-0020102){ref-type="table-fn"}     0.277
  MCH (pg)       0.087    0.177    −0.099   0.599[\*\*](#tfn6-0020102){ref-type="table-fn"}   0.525[\*\*](#tfn6-0020102){ref-type="table-fn"}
  MCHC (g/dl)    0.053    0.277    −0.109   0.609[\*\*](#tfn6-0020102){ref-type="table-fn"}   0.540[\*\*](#tfn6-0020102){ref-type="table-fn"}

: The correlation at P\<.05 level (Pearson correlation coefficients).

: The correlation at P\<.01 level (Pearson correlation coefficients).

###### 

Correlations between serum and clinical parameters in S (−) (n=43).

  Parameters     PI       GI       BOP      PD       CAL
  -------------- -------- -------- -------- -------- --------
  RBC (106/μl)   0.155    −0.020   −0.031   −0.139   −0.068
  HGB (g/dl)     0.129    −0.105   0.074    −0.069   0.003
  HCT (%)        0.086    −0.167   −0.078   −0.224   −0.162
  FE (μg/dl)     0.079    −0.128   0.227    −0.018   −0.026
  FER (ng/dl)    −0.041   −0.094   0.147    −0.079   0.046
  MCV (fl)       −0.038   −0.236   −0.068   −0.176   −0.168
  MCH (pg)       0.049    −0.126   0.122    0.024    0.050
  MCHC (g/dl)    0.133    0.041    0.290    0.229    0.258

: The correlation at P\<.05 level (Pearson correlation coefficients).

: The correlation at P\<.01 level (Pearson correlation coefficients).
